Resources
Downloadable, review-ready PDFs you can forward to IT, compliance, procurement, finance, and clinical sponsors — no account required.
Ungated · no form · no email capture
The citable write-up — Duke imaging evidence, the randomised four-arm mechanism, and the study we intend to run. Volume III §10.1: the giveaway is the strategy.
Download the write-up (PDF) →20 handouts shown
Ungated citable write-up — Duke imaging evidence, the randomised four-arm mechanism, DiD vs raw drop, persistence, and the study ARKA intends to run. No form, no email capture.
Ungated one-pager for a CMO, VP of Care Management, or hospital medicine chair — the DRG incentive, the three Robinson rates, the opportunity gap, and the free retrospective extract. No form.
Ungated one-pager for a CFO, CMO, or physician representative — what the number is, how we know it is right, and what could go wrong. Generated from the same engine as the pay export. No form.
Ungated two-page brief — the published definition of a duplicate, both sensitivities, the exclusion cascade in full, and an illustrative public-sample figure. Generated from lib/tcoc/content/duplicate-brief.ts. No form.
Ungated one-pager — minimum field set for protocol, site, and temporal variance. Generated from the same typed constant as the ingest adapter. No form.
Ungated census of protocol variance from a declared synthetic RIS dataset. Figures labelled illustrative. Generated from protocolVariance(). No form.
The flagship leave-behind: what ARKA is, who it serves, and why health systems adopt it.
Stakeholder map and positioning guide for internal champions enabling a multi-department review.
CFO-forwardable business case covering denial reduction, utilization impact, and payback framing.
Ungated generated dossier — rollback, no FHIR scopes for the first product, committee map, data governance, data-flow, scopes, security posture, analyst hours. No form.
Epic-aligned rollout phases, integration touchpoints, and IT readiness checklist for go-live.
Scoped pilot design with success criteria, timeline, and governance for an innovation-led evaluation.
Answers to the questions IT, compliance, and procurement teams ask during vendor diligence.
Measurable outcomes and KPI definitions for CFO, CMIO, and utilization-management sponsors.
Data-flow diagram and PHI handling statement for privacy, compliance, and security reviewers.
Print-ready Value Analysis Committee submission — pre-filled from live pricing, evidence, security, and implementation data.
Meeker four-arm trial with DiD vs raw drop, 12-month persistence, wider behavioural evidence, mechanism taxonomy, ARKA's own correction, and what a default is.
Same Document A artefact — settled taxonomy with ARKA's position, correction, and default before/after JSON — published from /evidence/mechanisms.
Pre-deployment clinical governance packet — fire-rate ceilings, measured rates, mechanism status, firewall commitments, and J6 schema appendix. Watermarked SYNTHETIC.
One-page patient handout generated from the same script the clinician speaks — both arms, natural frequencies, return precautions. Watermarked SYNTHETIC. Not a live patient.
Go deeper
Security questionnaires, policy series, and controlled documents live in our Security document library (NDA). Prefer a guided walkthrough? Book time with our team.